Health Care • Biotechnology: Pharmaceutical Preparations
$161.10 ▲ +5.02
(+3.22%)
MKT CAP: $307.40B • VOL: 2.24M
52W L $123 52W H $170
NVS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
NO ANNUAL 10-K XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NVS.
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NVS.